These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26827658)

  • 1. Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease.
    Lee JJ; Oh JS; Ham JH; Lee DH; Lee I; Sohn YH; Kim JS; Lee PH
    Neurobiol Aging; 2016 Feb; 38():197-204. PubMed ID: 26827658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-dependent association of urate on the patterns of striatal dopamine depletion in Parkinson's disease.
    Baik K; Chung SJ; Yoo HS; Lee YH; Jung JH; Sohn YH; Lee PH
    Eur J Neurol; 2020 May; 27(5):773-778. PubMed ID: 31994785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
    Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS
    J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease.
    Caminiti SP; Presotto L; Baroncini D; Garibotto V; Moresco RM; Gianolli L; Volonté MA; Antonini A; Perani D
    Neuroimage Clin; 2017; 14():734-740. PubMed ID: 28409113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls.
    Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M
    BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nigrostriatal dopamine transporter availability in early Parkinson's disease.
    Fazio P; Svenningsson P; Cselényi Z; Halldin C; Farde L; Varrone A
    Mov Disord; 2018 Apr; 33(4):592-599. PubMed ID: 29436751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
    Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing speed is related to striatal dopamine transporter availability in Parkinson's disease.
    Vriend C; van Balkom TD; van Druningen C; Klein M; van der Werf YD; Berendse HW; van den Heuvel OA
    Neuroimage Clin; 2020; 26():102257. PubMed ID: 32344372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    Fazio P; Svenningsson P; Forsberg A; Jönsson EG; Amini N; Nakao R; Nag S; Halldin C; Farde L; Varrone A
    J Nucl Med; 2015 May; 56(5):714-20. PubMed ID: 25791993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Susceptibility Associates With Dopaminergic Deficits and Cognition in Parkinson's Disease.
    Uchida Y; Kan H; Sakurai K; Inui S; Kobayashi S; Akagawa Y; Shibuya K; Ueki Y; Matsukawa N
    Mov Disord; 2020 Aug; 35(8):1396-1405. PubMed ID: 32369660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors associated with the rate of progression of nigrostriatal degeneration in Parkinson's disease.
    Yoo HS; Kim HK; Lee HS; Yoon SH; Na HK; Kang SW; Lee JH; Ryu YH; Lyoo CH
    J Neurol; 2024 Aug; 271(8):5213-5222. PubMed ID: 38839638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson's disease.
    Pak K; Shin HK; Kim EJ; Lee JH; Lyoo CH; Son J; Lee MJ
    Parkinsonism Relat Disord; 2018 Jun; 51():67-72. PubMed ID: 29510907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender difference in the effect of uric acid on striatal dopamine in early Parkinson's disease.
    Oh YS; Kim JS; Yoo SW; Hwang EJ; Lyoo CH; Lee KS
    Eur J Neurol; 2020 Feb; 27(2):258-264. PubMed ID: 31446637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between heart rate variability and striatal dopamine depletion in Parkinson's disease.
    Kitagawa T; Umehara T; Oka H; Shiraishi T; Sato T; Takatsu H; Nakahara A; Matsuno H; Bono K; Omoto S; Murakami H; Sengoku R; Iguchi Y
    J Neural Transm (Vienna); 2021 Dec; 128(12):1835-1840. PubMed ID: 34559319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.
    Martín-Bastida A; Lao-Kaim NP; Roussakis AA; Searle GE; Xing Y; Gunn RN; Schwarz ST; Barker RA; Auer DP; Piccini P
    Brain; 2019 Jul; 142(7):2023-2036. PubMed ID: 31056699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease.
    Gigante AF; Asabella AN; Iliceto G; Martino T; Ferrari C; Defazio G; Rubini G
    Neurol Sci; 2018 Mar; 39(3):551-555. PubMed ID: 29362953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.